Abstract OBJECTIVES: Exercise testing is an additional tool to standard pulmonary assessment before radical pulmonary resection in lung cancer patients. Evidence is lacking, supporting the significance of routine implementation of these simple physiological tests in preoperative evaluation.
INTRODUCTION
Currently, established guidelines for testing pulmonary function allow for formal patient assessment, before surgery or chemoradiation therapy, with radical intent. These standards have been published. Due to the general consensus of experts and validation studies, they were routinely applied. Formal acceptance of patients to surgery with low cardiac risk are based on spirometry and diffused lung carbon monoxide capacity (DLCO). In case of poor results, cardiopulmonary exercise test (CPET) should be performed and a predicted postoperative ( ppo) percent of predicted value of forced expiratory volume in 1 s (FEV1%) as well as DLCO should be assessed [1] . Other complimentary tests to CPET can be used as a screening tool before formal assessment.
Simple, physiological tests offer instant, rough evaluation of patient's general cardiopulmonary physiological status [2, 3] . Despite the fact that no physiological exercise test precisely assesses physiological status, their implementation to the daily routine increases. The set of exercise tests that are currently implemented have some disadvantages. Advanced technical devices, necessary for CPET, decrease common availability of this procedure. Simple physiological tests such as 6-min walk test (6MWT), shuttle walk test or stair climbing test do not require advanced technical equipment. These tests can be performed easily without a physician [4] . These tests are widely implemented. They allow for initial screening, while recording dynamic changes in a patient's status [5] . Moreover, the shuttle walk test, stair climbing test and 6MWT are proven to correlate with peak O 2 consumption [6] [7] [8] [9] . 6MWT provides the clinician with obvious, crude result of the distance walked during 6 min. The only task of the clinician is to interpret the unequivocal result in specific clinical situation. Conversely, other physiological tests lead to interpretation difficulties. The classic stair climbing test stratifies the patients to two groups of patients: those who reached the desired height, and those who did not. This test works in favour of tall patients, making the assessment of short patients unreliable. Symptom-limited way of performing stair climbing test or shuttle walk test provides clinician with the result obtained by patients' exhaustion. This may be difficult to tolerate or even risky in the most interesting group of borderline patients. The walk test is safe even in this group of patients. The major disadvantage of 6MWT is its poor reproducibility; however, obtained results promise to be a useful tool for risk stratification.
The aim of the study was to evaluate the cut-off value of crude 6-min walk distance (6MWD), identifying the group of patients with elevated postoperative risk. The additional aim was to validate Enright and Sherrill's reference equations for the 6-min walk in healthy adults for the risk stratification. The reference values are derived from equations calculated in the healthy population [10] . This formula is re-evaluated in patients with medical conditions such as heart failure or chronic obstructive pulmonary disease (COPD) but up to now the equation did not earn validation in physiological qualification for a pulmonary lobectomy.
MATERIALS AND METHODS
Between April 2009 and October 2011, 391 patients were operated in the Thoracic Surgery Department Medical University of Gdansk due to non-small-cell lung cancer (NSCLC). A homogenous group of 253 patients, who underwent lobectomy and had a 6-min walk test (6MWT) performed the day before surgery, were entered into this retrospective study. The detailed study design is described in Fig. 1 . Sixty-five patients, who did not undergo 6MWT due to existing comorbidities, were also analysed. The patients did not undergo the test due to (in order of incidence) lower limb disabilities and cerebral infarcts with persistent significant paresis. Table 1 presents the characteristics of 65 patients who did not perform 6MWT during the analysed study period.
We did not encounter patient refusal to perform the test. The prospectively collected data from the Polish National Lung Cancer Prospective Database (Krajowy Rejestr Raka Pluca) were matched with the results of 6MWT, routinely performed in the department.
All patients in the study underwent routine preoperative pulmonary evaluation, consisting of baseline spirometry. DLCO, ppo spirometry and ppoDLCO were assessed in selected patients with FEV1% lower than 80%. Prior to admission to the hospital and surgery, all patients with coronary heart disease, heart failure or other significant cardiovascular comorbidities were consulted by a cardiologist, focused on preoperative assessment of high-risk patients. Oncological and surgical therapeutic decisions were made during multidisciplinary clinician meetings. Stable or unstable coronary heart disease, and/or left ventricle ejection fraction of < 40% was an indication for arteriography and possible vascular intervention. The patients, not scheduled for surgical treatment due to significant coexisting morbidities, were accepted to stereotactic radiotherapy programme. The detailed data of patients not accepted for surgery due to medical conditions were not gathered for the purpose of this study. The 6MWT is not assumed to be a routine tool for evaluation for surgical resection. The validation studies do not allow daily, routine implementation of this test. 6MWT was performed as an additional procedure, in screening mode before further assessment. None of the patients was neither qualified nor disqualified from the procedure on the basis of 6MWT. Lobectomies were performed by postero-lateral muscle-sparing thoracotomy or by video-assisted thoracic surgery (VATS). In the postoperative period, pain was treated by a multidisciplinary analgesic team. Patients were treated with patient-controlled analgesia morphine pumps, or tittered with subcutaneous morphine, together with nonsteroidal anti-inflammatory drugs (NSAIDs), metamizol and paracetamol. Antibiotic prophylaxis, low-molecular-weight prophylaxis and gastric ulceration prophylaxis were routinely administered in postoperative patients, according to departmental protocols. The patients were extubated, as soon as possible, with the majority of them being extubated in the operating theatre. One pleural drain, 28-French, was left in the pleural cavity. After 24 h of external suction of −15 cmH 2 O, the patients were transferred to no external suction. Rehabilitation was started on the day of surgery. The patients were required to stand up and to walk on first postoperative day.
The complications were recorded in medical and nursing records and these were the source data for national database documentation. The general complications recorded are listed here: bleeding requiring reoperation, haematoma requiring reoperation, the need for transfusion of ≥2 units of blood, early bronchial stump fistula, persistent pneumothorax, pneumothorax requiring redrainage, wound infection, pleural empyema without fistula, prolonged air leak ≥7 days, late bronchial stump fistula, urinary tract infection, other infections, renal insufficiency, chylothorax, other complications requiring reoperation, other complications treated conservatively, paresis of recurrent laryngeal nerve. For the purposes of analysis, we extracted a group of cardiopulmonary complications that were also reported in the database: respiratory insufficiency requiring reintubation, atrial arrhythmia requiring treatment, ventricular arrhythmia requiring treatment, atelectasis requiring bronchial aspiration, prolonged mechanical ventilation, pneumonia, adult respiratory distress syndrome, respiratory insufficiency requiring tracheostomy, prolonged mechanical ventilation, myocardial infarct, pulmonary emboli, other respiratory complications, thrombophlebitis, other cardiovascular complications, sepsis, psychosis, cerebral infarct, other neurological complications, intraoperative death, death during hospitalization, other complications.
The patients were scheduled for the 6MWT on the day before surgery. The test was performed along the hospital corridor, which had a length of 33 m. Two certified physiotherapists supervised the tests. During each test, a physician was available to defibrillate a patient if necessary. The physiotherapists had been extensively trained in administering basic life support. The tests were performed according to the guidelines of the American Thoracic Society [4] . The blood pressure was measured before and after every test. Every patient was allowed to stop during the test, depending on fatigue or other symptoms. These incidents were recorded, but did not affect the crude result of 6MWD.
In order to generalize the results of 6MWD and to raise the applicability of the test, the Enright and Sherrill's reference equations for the 6-min walk were applied. On the basis of arithmetical evaluation, the authors proposed a gender-specific formula: for woman (7.57 × height cm ) − (5.02 × years of age) − (1.76 × weight kg ) − 309 m and for man (2.11 × height cm ) − (2.29 × weight kg ) − (5.78 × years of age) + 667 m [10] . The result of the reference equation was assumed as 100% of reference value.
The follow-up was recorded for every patient in the study group and for everyone from the group of 65 patients who did not undergo 6MWT. The 30-day mortality and 90-day mortality are presented in Tables 1 and 2. Unpaired data, characterized by normal distribution, were compared with unpaired t-test. In the case of non-normal distribution, a Mann-Whitney U-test was applied for comparing two unmatched samples. The χ 2 test was used for categorical variables. The accepted level of significance was P = 0.05. Odds ratios (ORs) were calculated with 95% confidence interval (CI). The threshold values of 6MWD, the percent of reference value of 6MWT, were based on maximum area under (AUC) receiver operating characteristic (ROC) curve.
Due to the retrospective nature of the study and the lack of experimental intervention in study group, institutional review board decided to waive the informed consent.
RESULTS
The distribution of the distance walked during the test is presented in Fig. 2 . Patient characteristics are presented in Table 2 . Patients who did not reach the distance of 500 m had worse spirometry results, and were older. Other cut-off values did not demonstrate any significant correlations in patients. The complication rates in different study groups are presented in Table 3 . The general complication rate and non-surgical cardiopulmonary complications rate were higher in the groups of patients with poorer results of 6MWT and 6MWD% and the trends were close to linear (Fig. 3) .
Spirometry parameters, age, smoking habit, packs of smoked cigarettes per day, pack per years, VATS approach, 6MWD and percent of predicted 6MWD were the factors assessed in univariate analysis of the general complications rate. 6MWD (P = 0.0008), percent of predicted 6MWD (P = 0.0096) and age (P = 0.0132) entered multivariate analysis. In logistic regression, age was found not to have a significant influence on the risk of complications.
Results of 6MWD and percent of reference value of 6MWT were confronted with complication rate providing simultaneous description of sensitivity and specificity. Five hundred metre distance had the highest AUC, and thus, presented the greatest discrepancy between high complication and low complication rates (AUC = 0.593; 95% CI: 0.530-0.654; sensitivity = 36.; 95% CI: 27.7-46.5; specificity = 81.9 95% CI: 74.7-87.9). One hundred percent predicted 6MWD had the highest AUC, which differentiated complication rate groups (AUC = 0.570; 95% CI: 0.507-0.632; sensitivity = 32.1; 95% CI: 23.5-41.7; specificity = 81.9; 95% CI: 74.7-87.9). When 6MWD and percent of predicted 6MWD were analysed simultaneously, the cut-off lines were 510 m and 105%, respectively (AUC = 0.582; 95% CI: 0.519-0.643; sensitivity = 30.3; 95% CI: 21.8-39.8; specificity = 86.1; 95% CI: 79.4-91.3) (Fig. 4) .
A univariate analysis of cardiopulmonary complications included age, 6MWD and FEV1%. In a multivariate logistic regression analysis, age seemed to have no influence on the risk of occurrence of cardiopulmonary complications. FEV1% (P = 0.02; OR: 1.03 95% CI: 1.00-1.06) and especially 6MWD <500 m (P < 0.01; OR: 2.60; 95% CI: 1.28-5.30) were found to have significant influence on increased risk of occurrence of cardiopulmonary complications.
There were no postoperative in-hospital deaths. The 30-day and 3-month mortality in the whole study group was 0.4% (1 of 253). The 30-day mortality in the group of 65 patients who did not undergo 6MWT was 1.5% (1 of 65), and did not significantly differ from the study group (P = 0.298). The patients who did not perform 6MWT had significantly a higher 90-day mortality of 7.6% (5 of 65) (P < 0.001; OR: 21.00 95% CI: 2.32-484.12).
A weak correlation between pulmonary function tests and 6MWD was found. Forced vital capacity (FVC) (r = 0.473 P < 0.001) and FEV1 (r = 0.465; P < 0.001) positively correlate with 6MWD while FEV1% correlates with 6MWD% (r = 0.225; P = 0.016).
DISCUSSION
Physiological qualification for pulmonary resection poses a difficult challenge, as reflected by the 30-and 90-day mortalities, as well as, lung function and quality of life. Despite standard protocols, which include technically advanced tests, the impact of these protocols may be limited. The aim of the study was to assess the 
: forced expiratory volume; FEV1%: percent of predicted value of forced expiratory volume in 1 s; FVC: forced vital capacity; FVC%: percent of predicted value of forced vital capacity; 6MWT: 6-min walk test; 6MWD: 6-min walk distance; 6MWD%: percent of predicted value of 6-min walk distance; VATS: video-assisted thoracic surgery. routine use of 6MWT for pulmonary lobectomy. Our study revealed a significant increase in complication rates in patients, who walked <500 m within 6 min (or 100% of predicted value). The complication rate was 40% higher in this group of patients, which had not been previously reported. Holden et al. [8] reported that 6MWT is a useful parameter for predicting 90-day mortality, and the prolonged mechanical ventilation in high-risk patients with FEV1 < 1.6 l. In our study, both 30-and 90-day mortalities, in all group of patients who underwent 6MWT, remained as low as 0.4%. We have found increased 90-day mortality among patients who had not performed 6MWT, but who had normal pulmonary function tests (Table 1) . This result is difficult to interpret, but we assume that disabilities of lower limbs resulting in inability to walk seriously impede the appropriate physiological qualification and that is why this group of patients requires special attention. In constrast, Bagg [11] proved that a 12-min walk test does not identify increased risk of postoperative complications [11] . Although these results are interesting, their accuracy is limited due to small study group size (16 patients in Holden's study, 30 patients in Bagg's study). To our knowledge, we present the largest series, thus far, on a homogenous group of 253 patients who underwent lobectomy. Functional tests deserve common application in routine cardiopulmonary assessment. 6MWT, shuttle walk test, stair climbing test and self-paced walking test have been thoroughly studied in chronic obstructive pulmonary disease and heart failure. Patients with cardiac arrhythmias, end-stage lung disease, interstitial lung disease and lung transplant recipients may be monitored with the use of the functional tests [12] . In our opinion, 6MWT should be implemented in the basic initial routine for preoperative risk assessment and qualification for resection.
Initially, the stair climbing test gained attention, despite its technical aspects raising bias in comparing results of different study centres. The applicability of the shuttle walk test is well documented [6, 7] ; however, it requires some technical assessment. The shuttle walk test is not easily accepted in borderline patients, because the result is obtained when patients are exhausted which exaggerates the health risk of the physiological test. 6MWT astonishes with its obvious result. The test provides the clinician with an exact distance in which a patient can walk within 6 min. As with other exercise tests, young, tall, thin males perform well in the 6MWT. An arithmetical formula, adjusting the crude result to gender, age, weight and height, offers an easy interpretation of the test [10] . 6MWT distance together with its reference value is a very useful tool for either screening for physiological preoperative evaluation or postoperative risk assessment.
Low tech exercise tests may be used to assess the risk before pulmonary resection. First, the low tech exercise test can be used to replace or to complement high tech tests, which will result in rearrangement of classic algorithms. Secondly, the low tech exercise test can be used to correlate exercise test results with VO 2 consumption. If significant correlation is confirmed, it may be possible to reliably replace CPET, in order to retain well-proven guidelines. Studies exist, proving a high correlation between 6MWD and VO 2 max or maximal work capacity in COPD patients [9] , which may be adapted for patients qualifying for pulmonary resection. However, current data are insufficient. Therefore, we cannot recommend replacing the CPET.
The study has some limitations. The 6MWT was not performed in the diverse group of 65 patients. Selection bias exists in the present study as well as in most exercise test studies. Most of the patients with a high perioperative risk due to comorbidities could not be included. On the other hand, we did not exclude the patients who had severe lower limb arterial insufficiency. In our opinion, the limitation of 6MWD, due to insufficient arterial blood inflow, represents disease present also in coronary, cerebral and visceral arteries, and could be a significant predictor of postoperative cardiovascular complications.
The methodology applied in the evaluation of the relevant thresholds of either 6MWD or percent of the reference value of 6MWT was based on sensitivity and specificity. Regardless of their independent clinical relevance, combining them together in ROC curves may be beneficial in assessing a diagnostic test. Herein, calculating AUC of the ROC curves for a set of thresholds allowed for the most adequate discrimination between patients with and without postoperative complications. However, the maximum AUC value did not exceed the value of 0.6, suggesting poor reliability. As with other studies concerning NSCLC patients, further external validation, as well as, an improvement in the initially established prediction model can increase the AUC value [13] . Therefore, our results should be regarded as a vital element of 6MWT pretest.
We conclude that 6MWT is a significant and an easily obtained predictor of postoperative complication rate and the length of hospital stay after lobectomy in NSCLC patients. A simple test may have the potential to supplement the physiological qualification for pulmonary surgery. 6MWT seeks to identify a high-risk group of patients in whom surgeon should optimize monitoring, care and treatment in order to reduce the complication rates.
